Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
CONMED Corporation CNMD
$119.95
-$2.21 (-1.84%)
На 18:00, 12 мая 2023
-9.96%
Потенциал через год
Ранг: 1
Ключевые показатели
-
Marketcap
3739970696.00000000
-
week52high
129.65
-
week52low
71.09
-
Revenue
1045472000
-
P/E TTM
-41
-
Beta
1.37854600
-
EPS
-3.18000000
-
Last Dividend
0.80000000
-
Next Earnings Date
25 июл 2023 г. в 10:59
Описание компании
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Needham | Buy | Buy | 02 авг 2022 г. |
| Piper Sandler | Overweight | Overweight | 28 июл 2022 г. |
| Needham | Buy | Buy | 28 июл 2022 г. |
| Stifel | Buy | Buy | 23 июн 2022 г. |
| Needham | Buy | Buy | 05 мая 2022 г. |
| Needham | Buy | Buy | 14 окт 2022 г. |
| Jefferies | Hold | 12 окт 2022 г. | |
| Needham | Buy | Buy | 15 ноя 2022 г. |
| Piper Sandler | Overweight | Overweight | 03 февр 2023 г. |
| Needham | Buy | Buy | 03 февр 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Jonas Daniel S | A | 12284 | 24 | 30 дек 2022 г. |
| Hartman Curt R | D | 83500 | 5118 | 13 дек 2022 г. |
| Hartman Curt R | D | 88618 | 382 | 13 дек 2022 г. |
| Garner Todd W | D | 35100 | 4500 | 09 дек 2022 г. |
| Garner Todd W | D | 1 | 4500 | 09 дек 2022 г. |
| Garner Todd W | A | 4501 | 4500 | 09 дек 2022 г. |
| Jonas Daniel S | A | 12260 | 26 | 30 сент 2022 г. |
| Hartman Curt R | D | 10299 | 3500 | 15 сент 2022 г. |
| Peters Stanley W III | D | 17500 | 7500 | 12 авг 2022 г. |
| Peters Stanley W III | D | 63 | 7500 | 12 авг 2022 г. |
Новостная лента
CONMED (CNMD) Beats on Q1 Earnings, Ups '23 EPS View
Zacks Investment Research
27 апр 2023 г. в 07:37
CONMED's (CNMD) adjusted first-quarter sales and earnings recover from the disruption in the fourth quarter due to implementation of a new warehouse management system.
CONMED Corporation (CNMD) Q1 2023 Earnings Call Transcript
Seeking Alpha
26 апр 2023 г. в 23:06
CONMED Corporation (CNMD) Q1 2023 Earnings Call Transcript.
CONMED Corporation to Announce First Quarter 2023 Financial Results on April 26, 2023
Business Wire
04 апр 2023 г. в 16:05
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2023 after the market close on Wednesday, April 26, 2023. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode.
Here's Why You Should Retain CONMED (CNMD) Stock for Now
Zacks Investment Research
04 апр 2023 г. в 14:28
Investors continue to be optimistic about CONMED (CNMD), owing to its broad product spectrum.
CNMD Stock: 4.34% Decrease Explained
Pulse2
05 февр 2023 г. в 17:57
The stock price of Conmed Corp (NYSE: CNMD) fell by 4.34% in the most recent trading session. This is why.